Asymmetric Dimethylarginine and Progression of Chronic Kidney Disease - a One-Year Follow-Up Study
Background/Aims: Asymmetric dimethylarginine (ADMA) is a prognostic factor in patients with chronic kidney disease (CKD). However, the relationships among factors influencing the metabolism of ADMA and the CKD progression are not fully understood. Methods: Serum ADMA, and variables related to the me...
Saved in:
Main Authors: | Jaromír Eiselt (Author), Daniel Rajdl (Author), Jaroslav Racek (Author), Michal Vostrý (Author), Kamila Rulcová (Author), Jan Wirth (Author) |
---|---|
Format: | Book |
Published: |
Karger Publishers,
2014-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Early Exercise Training After Renal Transplantation and Asymmetric Dimethylarginine: The Effect of Obesity
by: Vladimír Teplan, et al.
Published: (2014) -
Previous Vaccination and Age are More Important Predictors of Immune Response to Influenza Vaccine than Inflammation and Iron Status in Dialysis Patients
by: Jaromír Eiselt, et al.
Published: (2016) -
Study of endothelial dysfunction and asymmetric dimethylarginine levels
by: Ya. V. Sirman, et al.
Published: (2019) -
The Role of Asymmetric Dimethylarginine in the Pathogenesis of Hypertension in Children
by: N.N. Kaladze, et al.
Published: (2013) -
Increased Serum Levels of Asymmetric Dimethylarginine and Symmetric Dimethylarginine and Decreased Levels of Arginine in Sudanese Patients with Essential Hypertension
by: Sahar Gamil, et al.
Published: (2020)